ArticleInterdisciplinary sciences, computational life sciences2026
Interpretable Multimodal Molecular Language Model for Drug-Target Interaction Prediction.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate prediction of drug-target interactions (DTI) plays a vital role in accelerating drug discovery through multimodal data integration. While deep learning has shown significant potential for DTI prediction, its effectiveness is fundamentally limited by the scarcity of labeled training data, due to the expensive and time-consuming nature of experimental DTI validation. This constraint substantially hinders the full utilization of deep learning capabilities in computational drug discovery. Therefore, we propose an interpretable multimodal molecular language network to enhance DTI prediction, named M3LNet. Specifically, we first construct the multimodal network of the multiple perspectives of a drug, and then extract both the multimodal features of the drug and the features of the target sequence. Then, we employ a multikernel approach to learning different distributions of multimodal data. After that, we integrate large language models into the heterogeneous neural network, enabling knowledge-aware representation learning and contextual interaction prediction to label potential labeled data of DTI. Extensive experiments on publicly accessible datasets demonstrate that M3LNet significantly outperforms state-of-the-art methods on various tasks. Furthermore, we also visualize the attention weights of DTI to interpret DTI prediction, aiding researchers in understanding the mechanisms behind potential DTI. In summary, M3LNet provides an effective and interpretable approach for DTI prediction, facilitating both drug discovery and rational drug design.
Indexed as
Identifiers
41571978What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.